NDC 0003-7125
Opdualag 4 mg per 1 mL / 12 mg per 1 mL injection
On the label: E.R. Squibb & Sons, L.L.C..
Where it's made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants E.R. Squibb & Sons, L.L.C. names for other drugs.
Recalls
- Oct 21, 2025 · Class II · Bristol-Myers Squibb Company
Lack of Assurance of Sterility.
Lots: Lot: 033A23B, Expiry: 4/30/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Nivolumab and Relatlimab: every company that makes it
- Form
- injection, intravenous
- Strength
- 4 mg per 1 mL / 12 mg per 1 mL
- Approval
- BLA BLA761234
- On the market since
- Mar 18, 2022
- Package NDCs
0003-7125-11- Official label
- DailyMed (National Library of Medicine), updated Jun 8, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?